A Phase 1, Open-Label, Drug-Drug Interaction Study Between Methadone and BMS-663068; and Between Buprenorphine/Naloxone and BMS-663068
Phase of Trial: Phase I
Latest Information Update: 01 Aug 2017
At a glance
- Drugs Fostemsavir (Primary) ; Buprenorphine/naloxone; Methadone
- Indications Cancer pain; Opioid abuse
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 18 Jul 2016 Status changed from recruiting to completed.
- 15 Jun 2016 Planned End Date changed from 1 Aug 2016 to 1 Jun 2016.
- 15 Jun 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Jun 2016.